O'Shaughnessy Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,786	Closed	-$518K	–	2308
2020 Q3	$518K	Buy	9,786 +2,228	+29%	+$138K	0.02%	438
2020 Q2	$464K	Buy	7,558 +5,894	+354%	+$341K	0.01%	418
2020 Q1	$95K	Buy	1,664 +1,571	+1,689%	+$89.5K	﹤0.01%	636
2019 Q4	$5K	Buy	+93	New	+$4.93K	﹤0.01%	1481

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

O'Shaughnessy Asset Management's BSTC Position: Q4 2020 in Review

O'Shaughnessy Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 9,786 shares — an estimated $518K sold.

O'Shaughnessy Asset Management first reported a position in BSTC in Q4 2019 and held it in 4 quarters. The position peaked at $518K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

O'Shaughnessy Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
O'Shaughnessy Asset Management sold 9,786 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $518K.
O'Shaughnessy Asset Management first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 4 quarters.
O'Shaughnessy Asset Management's BioSpecifics Technologies Corp. position peaked at $518K in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.